| Neuroinflammation in Alzheimer's disease MT Heneka, MJ Carson, J El Khoury, GE Landreth, F Brosseron, ... The Lancet Neurology 14 (4), 388-405, 2015 | 5292 | 2015 |
| NLRP3 inflammasome activation drives tau pathology C Ising, C Venegas, S Zhang, H Scheiblich, SV Schmidt, A Vieira-Saecker, ... Nature 575 (7784), 669-673, 2019 | 935 | 2019 |
| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 450 | 2016 |
| Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s disease: a comparative overview F Brosseron, M Krauthausen, M Kummer, MT Heneka Molecular neurobiology 50, 534-544, 2014 | 435 | 2014 |
| Basal forebrain atrophy along the Alzheimer’s disease spectrum and its relevance for subjective cognitive decline S Li, MJ Grothe, M Daamen, S Wolfsgruber, F Brosseron, K Buerger, ... | 174 | 2020 |
| Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) F Jessen, A Spottke, H Boecker, F Brosseron, K Buerger, C Catak, ... Alzheimer's research & therapy 10, 1-10, 2018 | 173 | 2018 |
| Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia A Lučiūnaitė, RM McManus, M Jankunec, I Rácz, C Dansokho, ... Journal of neurochemistry 155 (6), 650-661, 2020 | 125 | 2020 |
| Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study L Miebach, S Wolfsgruber, A Polcher, O Peters, F Menne, K Luther, ... Alzheimer's research & therapy 11 (1), 1-14, 2019 | 101 | 2019 |
| Mediterranean diet, Alzheimer disease biomarkers, and brain atrophy in old age T Ballarini, D Melo van Lent, J Brunner, A Schröder, S Wolfsgruber, ... Neurology 96 (24), e2920-e2932, 2021 | 100 | 2021 |
| Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease N Franzmeier, E Düzel, F Jessen, K Buerger, J Levin, M Duering, ... Brain 141 (4), 1186-1200, 2018 | 92 | 2018 |
| Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease F Brosseron, A Traschütz, CN Widmann, MP Kummer, P Tacik, ... Alzheimer's research & therapy 10, 1-14, 2018 | 79 | 2018 |
| Minor neuropsychological deficits in patients with subjective cognitive decline S Wolfsgruber, L Kleineidam, J Guski, A Polcher, I Frommann, S Roeske, ... Neurology 95 (9), e1134-e1143, 2020 | 75 | 2020 |
| Instruments and methods in proteomics C May, F Brosseron, P Chartowski, C Schumbrutzki, B Schoenebeck, ... Data Mining in Proteomics: From Standards to Applications, 3-26, 2011 | 75 | 2011 |
| Ultratrace enrichment of tyrosine phosphorylated peptides on an imprinted polymer S Helling, S Shinde, F Brosseron, A Schnabel, T Müller, HE Meyer, ... Analytical Chemistry 83 (5), 1862-1865, 2011 | 74 | 2011 |
| The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease N Franzmeier, J Ren, A Damm, G Monté-Rubio, M Boada, A Ruiz, ... Molecular psychiatry 26 (2), 614-628, 2021 | 68 | 2021 |
| The central biobank and virtual biobank of BIOMARKAPD: a resource for studies on neurodegenerative diseases BLR Reijs, CE Teunissen, N Goncharenko, F Betsou, K Blennow, ... Frontiers in neurology 6, 216, 2015 | 49 | 2015 |
| PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment L Kleineidam, V Chouraki, T Próchnicki, SJ van Der Lee, ... Acta neuropathologica 139, 1025-1044, 2020 | 46 | 2020 |
| Tau plasma levels in subjective cognitive decline: Results from the DELCODE study S Müller, O Preische, JC Göpfert, VAC Yanez, TO Joos, H Boecker, ... Scientific reports 7 (1), 9529, 2017 | 44 | 2017 |
| Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients S Finsterwalder, N Vlegels, B Gesierich, MÁ Araque Caballero, ... Alzheimer's & Dementia 16 (11), 1504-1514, 2020 | 43 | 2020 |
| Dysregulation of TLR5 and TAM Ligands in the Alzheimer’s Brain as Contributors to Disease Progression M Herrera-Rivero, F Santarelli, F Brosseron, MP Kummer, MT Heneka Molecular Neurobiology 56, 6539-6550, 2019 | 39 | 2019 |
